J Appl Biomed 14:19-24, 2016 | DOI: 10.1016/j.jab.2015.07.001

Modulation of ionizing radiation-induced effects by NU7441, KU55933 and VE821 in peripheral blood lymphocytes

Adela Kmochovaa, Ales Tichya, Lenka Zarybnickaa, Zuzana Sinkorovaa, Jirina Vavrovaa, Vit Rehacekc, Kamila Durisovaa, Klara Kubelkovab, Jaroslav Pejchala,*, Kamil Kucad,*
a Department of Radiobiology, Faculty of Military Health Sciences in Hradec Kralove, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic
b Department of Molecular Biology and Pathology, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic
c Department of Blood Transfusion, Faculty Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic
d Biomedicine Research Center, Faculty Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic

We evaluated the impact of ataxia-telangiectasia mutated kinase inhibitor KU55933, DNA-dependent protein kinase inhibitor NU7441 and ataxia telangiectasia and rad3-related kinase inhibitor VE821 in human peripheral lymphocytes in vitro. The lymphocytes were divided into 5 groups: non-irradiated control, irradiated group (2 Gy) and 3 groups pretreated with inhibitors 30 min before irradiation. We used flow cytometry to evaluate phosphorylated H2AX (γ-H2AX) and cytotoxicity (Apoptest). Micronucleus assay was used to assess genotoxicity. After irradiation, γ-H2AX, incidence of micronuclei (MN), nucleoplasmatic bridges (NPBs) and nuclear buds in binuclear cells, MN in mononuclear cells and apoptosis were increased. KU55933 decreased γ-H2AX and inhibited ionizing radiation-induced cytotoxicity. NU7441 showed no effect on γ-H2AX but it significantly increased MN and NPBs in binuclear cells and apoptosis. VE821 decreased γ-H2AX, whereas genotoxicity and cytotoxicity were not affected. In conclusion, KU55933 protected lymphocytes, which might be employed to preserve the immune system during anticancer therapy. NU7441 radiosensitized lymphocytes, thus, undesirable side effects toward immune system could be expected. VE821 showed decrease of γ-H2AX with no radiosensitizing effects in our model likely due to p53 positive status, which underlies the concept of its application in p53 negative environment.

Keywords: Ionizing radiation; Lymphocytes; KU55933; NU7441; VE821

Received: April 20, 2015; Revised: July 7, 2015; Accepted: July 11, 2015; Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Kmochova A, Tichy A, Zarybnicka L, Sinkorova Z, Vavrova J, Rehacek V, et al.. Modulation of ionizing radiation-induced effects by NU7441, KU55933 and VE821 in peripheral blood lymphocytes. J Appl Biomed. 2016;14(1):19-24. doi: 10.1016/j.jab.2015.07.001.
Download citation

References

  1. Ciszewski, W.M., Tavecchio, M., Dastych, J., Curtin, N.J., 2014. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Breast Cancer Res. Treat. 143, 47-55. Go to original source... Go to PubMed...
  2. Cowell, I.G., Durkacz, B.W., Tilby, M.J., 2005. Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated. Biochem. Pharmacol. 71, 13-20. Go to original source... Go to PubMed...
  3. Fenech, M., 2000. The in vitro micronucleus technique. Mutat. Res. 455, 81-95. Go to original source... Go to PubMed...
  4. Fenech, M., 2006. Cytokinesis-block micronucleus assay evolves into a cytome assay of chromosomal instability, mitotic dysfunction and cell death. Mutat. Res. 600, 58-66. Go to original source... Go to PubMed...
  5. Havelek, R., Rezacova, M., Sinkorova, Z., Zarybnicka, L., Pejchal, J., Vavrova, J., 2011. Phosphorylation of histone H2AX in peripheral blood mononuclear cells after thoracic irradiation of rats. J. Appl. Biomed. 9, 209-218. Go to original source...
  6. Heyder, P., Gaipl, U.S., Beyer, T.D., Voll, R.E., Kern, P.M., Stach, C., Kalden, J.R., Herrmann, M., 2003. Early detection of apoptosis by staining of acid-treated apoptotic cells with FITC-labeled lectin from Narcissus pseudonarcissus. Cytometry A 55, 86-93. Go to original source... Go to PubMed...
  7. Hickson, I., Zhao, Y., Richardson, C.J., Green, S.J., Martin, N.M., Orr, A.I., Reaper, P.M., Jackson, S.P., Curtin, N.J., Smith, G.C., 2004. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152-9159. Go to original source... Go to PubMed...
  8. International Atomic Energy Agency, 2001. Biological Dosimetry: Chromosomal Aberration Analysis for Dose Assessment, Technical Reports Series No. 405. IAEA, Vienna.
  9. Knight, Z.A., 2010. Small molecule inhibitors of the PI3-kinase family. Curr. Top. Microbiol. Immunol. 347, 263-278. Go to original source... Go to PubMed...
  10. Kuo, L.J., Yang, L.X., 2008. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 22, 305-309. Go to PubMed...
  11. Landsverk, K.S., Patzke, S., Rein, I.D., Stokke, C., Lyng, H., De Angelis, P.M., Stokke, T., 2011. Three independent mechanisms for arrest in G2 after ionizing radiation. Cell Cycle 10, 819-829. Go to original source... Go to PubMed...
  12. Li, Y., Yang, D.Q., 2010. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt. Mol. Cancer Ther. 9, 113-125. Go to original source... Go to PubMed...
  13. Mi, J., Dziegielewski, J., Bolesta, E., Brautigan, D.L., Larner, J.M., 2009. Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase. PLoS ONE 4, e4395. Go to original source... Go to PubMed...
  14. Momcilović, O., Choi, S., Varum, S., Bakkenist, C., Schatten, G., Navara, C., 2009. Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G (2) but not G (1) cell cycle arrest in pluripotent human embryonic stem cells. Stem Cells 27, 1822-1835. Go to original source... Go to PubMed...
  15. Nutley, B.P., Smith, N.F., Hayes, A., Kelland, L.R., Brunton, L., Golding, B.T., Smith, G.C.M., Martin, N.M.B., Workman, P., Raynaud, F.I., 2005. Preclinical pharmatokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026. Br. J. Cancer 93, 1011-1018. Go to original source... Go to PubMed...
  16. O'Driscoll, M., Ruiz-Perez, V.L., Woods, C.G., Jeggo, P.A., Goodship, J.A., 2003. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33, 497-501. Go to original source... Go to PubMed...
  17. Prevo, R., Fokas, E., Reaper, P.M., Charlton, P.A., Pollard, J.R., McKenna, W.G., Muschel, R.J., Brunner, T.B., 2012. The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. Cancer Biol. Ther. 13, 1072-1081. Go to original source... Go to PubMed...
  18. Rosenzweig, K.E., Youmell, M.B., Palayoor, S.T., Price, B.D., 1997. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors Wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clin. Cancer Res. 3, 1149-1156.
  19. Rothkamm, S.B., Rothkamm, K., Prise, K.M., 2008. ATM acts downstream of ATR in the DNA damage response signalling of bystander cells. Cancer Res. 68, 7059-7065. Go to original source... Go to PubMed...
  20. Selvan, G.T., Bhavani, M., Vijayalakshmi, J., Paul Solomon, F.D., Chaudhury, N.K., Venkatachalam, P., 2014. Delayed mitogenic stimulation decreases DNA damage assessed by micronucleus assay in human peripheral blood lymphocytes after (60)co irradiation. Dose Response 12, 498-508. Go to original source... Go to PubMed...
  21. Shaheen, S.F., Znojek, P., Fisher, A., Webster, M., Plummer, R., Gaughan, L., Smith, G.C.M., Leung, H.Y., Curtin, N.J., Robson, C.N., 2011. Targeting the DNA double strand break repair machinery in prostate cancer. PLoS ONE 6, e20311. Go to original source... Go to PubMed...
  22. Sharma, A., Singh, K., Almasan, A., 2012. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol. Biol. 920, 613-626. Go to original source... Go to PubMed...
  23. Song, H., Hedayati, M., Hobbs, R.F., Shao, C., Bruchertseifer, F., Morgenstern, A., DeWeese, T.L., Sgouros, G., 2013. Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled antiEGFR antibody. Mol. Cancer Ther. 12, 2043-2054. Go to original source... Go to PubMed...
  24. Soussi, T., 2000. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann. NY Acad. Sci. 910, 121-137. Go to original source... Go to PubMed...
  25. Tichy, A., Novotna, E., Salovska, B., Sedlarikova, R., Pejchal, J., Zarybnicka, L., Vavrova, J., Sinkorova, Z., 2012. Radiosensitization of human leukaemic MOLT-4 cells by DNAdependent protein kinase inhibitor, NU7026. Acta Med. (Hradec Kralove) 55, 66-73. Go to original source... Go to PubMed...
  26. Tichy, A., Durisova, K., Salovska, B., Pejchal, J., Zarybnicka, L., Vavrova, J., Dye, N.A., Sinkorova, Z., 2014. Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441. Radiat. Environ. Biophys. 53, 83-92. Go to original source... Go to PubMed...
  27. Vavrova, J., Zarybnicka, L., Lukasova, E., Rezacova, M., Novotna, E., Sinkorova, Z., Tichy, A., Durisova, K., 2013. Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL60). Radiat. Environ. Biophys. 52, 471-479. Go to original source... Go to PubMed...
  28. Vilasová, Z., Rezácová, M., Vávrová, J., Tichý, A., Vokurková, D., Zoelzer, F., Reháková, Z., Osterreicher, J., Lukásová, E., 2008. Changes in phosphorylation of histone H2A.X and p53 in response of peripheral blood lymphocytes to gamma irradiation. Acta Biochim. Pol. 55, 381-390. Go to original source... Go to PubMed...
  29. Vrouwe, M.G., Pines, A., Overmeer, R.M., Hanada, K., Mullenders, L.H., 2011. UV-induced photolesions elicit ATR-kinasedependent signaling in non-cycling cells through nucleotide excision repair-dependent and -independent pathways. J. Cell Sci. 124, 435-446. Go to original source... Go to PubMed...
  30. Xue, L., Yu, D., Furusawa, Y., Okayasu, R., Tong, J., Cao, J., Fan, S., 2009. Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation. Mutat. Res. 670, 15-23. Go to original source... Go to PubMed...
  31. Yamauchi, M., Oka, Y., Yamamoto, M., Niimura, K., Uchida, M., Kodama, S., Watanabe, M., Sekine, I., Yamashita, S., Suzuki, K., 2008. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling. DNA Repair 7, 405-417. Go to original source... Go to PubMed...
  32. Yu, L., Tumati, V., Tseng, S., Hsu, F., Kim, D.N., Hong, D., Hsieh, J., Jacobs, C., Kapur, P., Saha, D., 2012. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor. Neoplasia 14, 1203-1212. Go to original source... Go to PubMed...
  33. Zhao, Y., Thomas, H.D., Batey, M.A., Cowell, I.G., Richardson, C. J., Griffin, R.J., Calvert, A.H., Newell, D.R., Smith, G.C., Curtin, N.J., 2006. Preclinical evaluation of a potent novel DNAdependent protein kinase inhibitor NU7441. Cancer Res. 66, 5354-5362. Go to original source... Go to PubMed...